Exocrine Pancreatic Insufficiency Market Tends to Grow by New RESULT Trail Exposed with Advancements
Various kinds of diagnostic tests like blood tests, endoscopic ultra-sonography, magnetic resonance imaging, CT scanning and some others, are available in the market to detect EPI disease. Pancreatitis symptoms are Diarrhoea, Steatorrhea, fatigue and weight loss. EPI disturbs the normal growth, life expectancy and immune response. Increasing number of diseases like cystic fibrosis, chronic pancreatitis and diabetes is one of the key growth driver for the Exocrine Pancreatic Insufficiency Market.
Rising number of people suffering from diabetes and increasing demands for advanced therapies are the prime growth drivers of Exocrine Pancreatic Insufficiency Market. In addition, emergence of New Chemical Entities (NCEs) in various phases of clinical trials will create new opportunities for the market. Among all the tests, CT scanning is having the highest market share.
However, higher cost of EPI R & D and stringent government regulations or the approval of Pancreatic Enzyme Replacement Therapy (PERT) products are the key restraints for the Exocrine Pancreatic Insufficiency Market. But, presence of significant number of pipeline drugs encourages the market to drive the fast growth.
North America is dominating the Exocrine Pancreatic Insufficiency Market due to rapidly growing incidences of exocrine pancreatic insufficiency and other causative diseases like CF & CP in the US. It is also projected to have the fastest growth during the forecast period. Asia-Pacific is in the next position followed by Europe.
- Lyme Disease Diagnostic Devices Market Analysis: By Diagnostic Tests (Serological, Lymphocytic Transformation, PCR Analysis, Immunofluorescence Staining); By Technologies (Echocardiogram, MRI, Electrocardiogram, Flow Cytometry) - Forecast (2017 -2022)
- Allergy Diagnostics Market: By Allergy Type (Allergies: Food, Seasonal, Drug, Others) Diagnostic Test Type (In Vivo Test, In Vitro Test, Others) Product Type (Assays, Consumables, Others) End Users (Diagnostic & Research Institutes, Others)-Forecast(2017-2022)